Mavenclad (cladribine)

pCPA File Number: 21068
Negotiation Status:
Concluded with an LOI
Indication(s):
Multiple Sclerosis, Relapsing-Remitting
Sponsor/Manufacturer:
EMD Serono Canada, a division of EMD Inc.
CDA-AMC Project Number:
SR0546-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: